Early research (Phase 1)Study completedNCT00280826What this trial is testingEfalizumab to Treat UveitisWho this might be right forUveitisMacular Edema National Eye Institute (NEI) 6
Large-scale testing (Phase 3)Looking for participantsNCT05486468What this trial is testingThe Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior SegmentWho this might be right forUveitisUveitis, PosteriorUveitis, Anterior+1 more Texas Retina Associates 30
Large-scale testing (Phase 3)Study completedNCT00404612What this trial is testingLX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-UveitisWho this might be right forUveitis, PosteriorUveitis, IntermediatePanuveitis Lux Biosciences, Inc. 218
Large-scale testing (Phase 3)Study completedNCT00333814What this trial is testingThe Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior UveitisWho this might be right forIntermediate UveitisPosterior Uveitis Allergan 229
Post-approval studies (Phase 4)WithdrawnNCT05101928What this trial is testingOzurdex Monotherapy TrialWho this might be right forUveitis, PosteriorUveitis, IntermediatePanuveitis Ottawa Hospital Research Institute
Testing effectiveness (Phase 2)Study completedNCT00615693What this trial is testingSafety, Tolerability, and Efficacy of AEB071 in the Treatment of UveitisWho this might be right forUveitisPosterior UveitisPanuveitis Novartis 13
Large-scale testing (Phase 3)Study completedNCT00404742What this trial is testingLX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-UveitisWho this might be right forUveitis, PosteriorUveitis, IntermediatePanuveitis Lux Biosciences, Inc. 232
Large-scale testing (Phase 3)Study completedNCT01694186What this trial is testingSafety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal InsertWho this might be right forNon-Infectious Uveitis EyePoint Pharmaceuticals, Inc. 129
Testing effectiveness (Phase 2)Study completedNCT01789320What this trial is testingSafety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat UveitisWho this might be right forUveitisIntermediate UveitisPosterior Uveitis+2 more Clearside Biomedical, Inc. 11
Large-scale testing (Phase 3)Study completedNCT02748512What this trial is testingUtilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious UveitisWho this might be right forNon-Infectious Uveitis EyePoint Pharmaceuticals, Inc. 26
Not applicableEnded earlyNCT02951975What this trial is testingOzurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the EyeWho this might be right forNon-infectious Uveitis Allergan 246
Early research (Phase 1)Study completedNCT00078689What this trial is testingDaclizumab and Sirolimus to Treat UveitisWho this might be right forUveitis National Eye Institute (NEI) 6
Large-scale testing (Phase 3)Ended earlyNCT01032915What this trial is testingSafety and Efficacy of AIN457 in Patients With Quiescent Non-infectious UveitisWho this might be right forNon-infectious Uveitis Novartis Pharmaceuticals 125
Post-approval studies (Phase 4)UnknownNCT06085079What this trial is testingIxekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept StudyWho this might be right forUveitis, PosteriorUveitis, AnteriorUveitis, Intermediate+1 more Massachusetts Eye Research and Surgery Institution 20
Not applicableStudy completedNCT03155243What this trial is testingImpact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical PracticeWho this might be right forUveitis AbbVie 155
Large-scale testing (Phase 3)WithdrawnNCT01103024What this trial is testingExtension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious UveitisWho this might be right forUveitis Novartis
Testing effectiveness (Phase 2)Ended earlyNCT05953688What this trial is testingPOC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIUWho this might be right forUveitis Posterior Non-InfectiousUveitis, IntermediateNoninfectious Panuveitis Alumis Inc 36
Large-scale testing (Phase 3)Active Not RecruitingNCT06431373What this trial is testingBrepocitinib in Adults With Active, Non-Infectious, Non-Anterior UveitisWho this might be right forUveitis, PosteriorUveitis, IntermediateUveitis Priovant Therapeutics, Inc. 371
Post-approval studies (Phase 4)Study completedNCT02764697What this trial is testingStudy of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis PatientsWho this might be right forUveitisAnterior UveitisIntermediate Uveitis+3 more Tampa Bay Uveitis Center, LLC 6
Testing effectiveness (Phase 2)Study completedNCT01526889What this trial is testingSafety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,Who this might be right forNon-infectious Intermediate UveitisNon-infectious Posterior UveitisNon-infectious Panuveitis Novartis Pharmaceuticals 25